0001811355-22-000005.txt : 20220802 0001811355-22-000005.hdr.sgml : 20220802 20220802110307 ACCESSION NUMBER: 0001811355-22-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220802 DATE AS OF CHANGE: 20220802 EFFECTIVENESS DATE: 20220802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VITARA BIOMEDICAL, INC. CENTRAL INDEX KEY: 0001811355 IRS NUMBER: 843545298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-454119 FILM NUMBER: 221127353 BUSINESS ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 1535 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 267-518-6300 MAIL ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 1535 CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: Extend Device Corp DATE OF NAME CHANGE: 20200505 D/A 1 primary_doc.xml X0708 D/A LIVE 0001811355 VITARA BIOMEDICAL, INC. 2929 ARCH STREET SUITE 1535 PHILADELPHIA PA PENNSYLVANIA 19104 267-518-6300 DELAWARE Extend Device Corp Corporation true 2019 James McGlone 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Rosaleen Oskanian 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Executive Officer John Kelly 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Thomas Todorow 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Director Diem Nguyen 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Director Bernard Lyons 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Director Ian Ratcliffe 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Director Manish Kothari 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Director Ted Fjallman 2929 Arch Street Suite 1535 Philadelphia PA PENNSYLVANIA 19104 Director Biotechnology Decline to Disclose 06b true 0001811355-22-000004 2022-07-19 false true false 99000 74993216 24997738 49995478 false 9 0 0 0 true The gross proceeds of the offering will be used for general corporate purposes, which may include the salaries of certain persons listed in Item 3. false VITARA BIOMEDICAL, INC. James McGlone James McGlone President and Chief Executive Officer 2022-08-02